A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries

BMC Medicine

Stefan D. Baral¹  Sarah M. Murray²  Jeremy C. Kane²  Jura L. Augustinavicius²  Melissa A. Elafros³  Sara Causevic⁴  Ellen M. H. Mitchell⁵ 

[1] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health;Department of Mental Health, Johns Hopkins Bloomberg School of Public Health;Department of Neurology, Johns Hopkins School of Medicine;Department of Public Health Sciences, Karolinska Institutet, Widerströmska huset;International Institute for Social Studies, Erasmus University;

关键词: Stigma;    Low- and middle-income countries;    HIV;    Tuberculosis;    Epilepsy;    Depression;   

DOI  :  10.1186/s12916-019-1250-8

来源: DOAJ

【 摘 要 】

Abstract Background Stigma is associated with health conditions that drive disease burden in low- and middle-income countries (LMICs), including HIV, tuberculosis, mental health problems, epilepsy, and substance use disorders. However, the literature discussing the relationship between stigma and health outcomes is largely fragmented within disease-specific siloes, thus limiting the identification of common moderators or mechanisms through which stigma potentiates adverse health outcomes as well as the development of broadly relevant stigma mitigation interventions. Methods We conducted a scoping review to provide a critical overview of the breadth of research on stigma for each of the five aforementioned conditions in LMICs, including their methodological strengths and limitations. Results Across the range of diseases and disorders studied, stigma is associated with poor health outcomes, including help- and treatment-seeking behaviors. Common methodological limitations include a lack of prospective studies, non-representative samples resulting in limited generalizability, and a dearth of data on mediators and moderators of the relationship between stigma and health outcomes. Conclusions Implementing effective stigma mitigation interventions at scale necessitates transdisciplinary longitudinal studies that examine how stigma potentiates the risk for adverse outcomes for high-burden health conditions in community-based samples in LMICs.

【 授权许可】

Unknown